UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Pinduoduo
PDD
|
$1.65B |
| 2 |
Accenture
ACN
|
$1.54B |
| 3 |
Linde
LIN
|
$1.24B |
| 4 |
Prologis
PLD
|
$1.08B |
| 5 |
Microsoft
MSFT
|
$914M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$809M |
| 2 |
Blackrock
BLK
|
$809M |
| 3 |
Lam Research
LRCX
|
$735M |
| 4 |
Meta Platforms (Facebook)
META
|
$563M |
| 5 |
UBS Group
UBS
|
$411M |
Sector Composition
| 1 | Technology | 33.21% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Humacyte
HUMA
$226M
| $596K | ﹤0.01% |
+109,542
| New | +$596K |
|
2552
Digimarc
DMRC
$181M
| $594K | ﹤0.01% |
22,114
-3,414
| -13% | -$91.8K |
|
2553
Tyra Biosciences
TYRA
$674M
| $593K | ﹤0.01% |
+25,209
| New | +$593K |
|
2554
Standard BioTools
LAB
$497M
| $592K | ﹤0.01% |
306,871
-75,617
| -20% | -$146K |
|
2555
Pulse Biosciences
PLSE
$1.02B
| $588K | ﹤0.01% |
+33,535
| New | +$588K |
|
2556
fuboTV
FUBO
$1.37B
| $587K | ﹤0.01% |
413,568
-107,360
| -21% | -$152K |
|
2557
Y-mAbs Therapeutics
YMAB
$390M
| $586K | ﹤0.01% |
44,591
-13,708
| -24% | -$180K |
|
2558
Tango Therapeutics
TNGX
$772M
| $580K | ﹤0.01% |
75,302
-3,420
| -4% | -$26.3K |
|
|
TUYA
2559
Tuya Inc
TUYA
$1.53B
| $578K | ﹤0.01% |
350,116
+132,200
| +61% | +$218K |
|
|
ITOS
2560
DELISTED
iTeos Therapeutics
ITOS
| $577K | ﹤0.01% |
56,507
-2,333
| -4% | -$23.8K |
|
2561
Community Trust Bancorp
CTBI
$1.06B
| $572K | ﹤0.01% |
11,525
-2,453
| -18% | -$122K |
|
|
VERV
2562
DELISTED
Verve Therapeutics
VERV
| $557K | ﹤0.01% |
115,041
+6,595
| +6% | +$31.9K |
|
|
STKL
2563
SunOpta
STKL
$779M
| $555K | ﹤0.01% |
87,002
-232,339
| -73% | -$1.48M |
|
2564
Navitas Semiconductor
NVTS
$1.19B
| $554K | ﹤0.01% |
226,289
-39,995
| -15% | -$98K |
|
2565
U-Haul Holding Co
UHAL
$11.2B
| $552K | ﹤0.01% |
7,124
-6,732
| -49% | -$522K |
|
2566
Luminar Technologies
LAZR
$114M
| $549K | ﹤0.01% |
40,696
-2,014
| -5% | -$27.2K |
|
2567
EyePoint Pharmaceuticals
EYPT
$966M
| $548K | ﹤0.01% |
68,630
-10,616
| -13% | -$84.8K |
|
|
BITF
2568
Bitfarms
BITF
$713M
| $548K | ﹤0.01% |
259,722
-70,462
| -21% | -$149K |
|
|
SKE
2569
Skeena Resources
SKE
$1.99B
| $547K | ﹤0.01% |
+64,602
| New | +$547K |
|
2570
Rush Enterprises Class B
RUSHB
$4.61B
| $544K | ﹤0.01% |
11,345
-1,665
| -13% | -$79.8K |
|
2571
OmniAb
OABI
$246M
| $542K | ﹤0.01% |
128,202
-15,434
| -11% | -$65.3K |
|
2572
Evolv Technologies
EVLV
$1.39B
| $539K | ﹤0.01% |
133,209
-42,465
| -24% | -$172K |
|
|
CMRC
2573
Commerce.com, Inc. Series 1 Common Stock
CMRC
$361M
| $539K | ﹤0.01% |
92,149
-26,232
| -22% | -$153K |
|
2574
Savara
SVRA
$643M
| $533K | ﹤0.01% |
125,815
+6,141
| +5% | +$26K |
|
2575
Kura Sushi USA
KRUS
$985M
| $529K | ﹤0.01% |
6,572
+1,644
| +33% | +$132K |
|